| 摘要 |
This invention relates to novel solid compositions, e.g., tablets, pills, dispersible powders, granules, or capsules, containing as active ingredient the compound 4'-chloro-2-{[3-(10,11-dihydro-5H-dibenz(b,f)-azepinyl-(5)-propyl]-met hylamino}-acetophenone hydrochloride (in the following referred to as lofepramine hydrochloride).
|
